Showing results (1611-1620 of 3,401) with videos related to
Sort By:
Pageof 341
Neuromuscular Disorders : NMD|January 28, 2014
Clinical and pathological heterogeneity of a congenital disorder of glycosylation manifesting as a myasthenic/myopathic syndromeDorota M Monies, Hindi N Al-Hindi, Mohamed A Al-Muhaizea, et al.Neuromuscular Disorders : NMD|May 22, 2014
Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac functionN V Ermolova, L Martinez, S A Vetrone, et al.Neuromuscular Disorders : NMD|June 15, 2014
Conserved regions of the DMD 3' UTR regulate translation and mRNA abundance in cultured myotubesC Aaron Larsen, Michael T HowardNeuromuscular Disorders : NMD|June 27, 2020
Confounding clinical presentation and different disease progression in CMT4B1Raquel Guimarães-Costa, Rocio-Nur Villar-Quiles, Philippe Latour, et al.Neuromuscular Disorders : NMD|July 26, 2020
SMALED2 with BICD2 gene mutations: Report of two cases and portrayal of a classical phenotypeVincent Picher-Martel, Clément Morin, Denis Brunet, et al.Neuromuscular Disorders : NMD|January 25, 2015
Targeted sequencing and identification of genetic variants in sporadic inclusion body myositisConrad C Weihl, Robert H Baloh, Youjin Lee, et al.Neuromuscular Disorders : NMD|February 2, 2015
Mitochondrial pathology in inclusion body myositisUlrika Lindgren, Sara Roos, Carola Hedberg Oldfors, et al.Neuromuscular Disorders : NMD|October 16, 2012
Presymptomatic late-onset Pompe disease identified by the dried blood spot testMatias Wagner, Amina Chaouch, Juliane S Müller, et al.Neuromuscular Disorders : NMD|February 10, 2015
SCN4A mutation as modifying factor of myotonic dystrophy type 2 phenotypeE Bugiardini, I Rivolta, A Binda, et al.Neuromuscular Disorders : NMD|January 31, 2015
Studying the role of dystrophin-associated proteins in influencing Becker muscular dystrophy disease severityJ C van den Bergen, B H A Wokke, M A Hulsker, et al.Pageof 341